Regular epilation regimen only for Pilonidal Disease
Phase-Based Progress Estimates
Effectiveness
Safety
Stanford University School of Medicine, Palo Alto, CA
Pilonidal Disease
Regular Epilation Regimen - ProcedureEligibility
Any Age
All Sexes
What conditions do you have?
Select
Eligibility
Any Age
All Sexes
What conditions do you have?
Select
Study Summary
The goal is to evaluate whether surgical excision of the pilonidal disease is needed after resolution of the initial symptoms when the patient follows regular hair removal regimen such as laser epilation.
Treatment Effectiveness
Effectiveness Progress
Other trials for Pilonidal Disease
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: Up to 1 year
Baseline to 1 year
Effect on parent's daily activities
Up to 1 year
Number of participants requiring additional surgical intervention
Number of participants requiring antibiotic treatment
Number of participants with recurrent symptoms of pilonidal disease
Time taken off from school or work due to pilonidal disease
Trial Safety
Safety Progress
Other trials for Pilonidal Disease
Trial Design
2 Treatment Groups
Regular epilation regimen only
1 of 2
Regular epilation regimen with surgical excision
1 of 2
Active Control
400 Total Participants · 2 Treatment Groups
Primary Treatment: Regular epilation regimen only · No Placebo Group · N/A
Regular epilation regimen only
Procedure
ActiveComparator Group · 1 Intervention: Regular Epilation Regimen · Intervention Types: ProcedureRegular epilation regimen with surgical excisionActiveComparator Group · 2 Interventions: Regular Epilation Regimen, Surgical excision · Intervention Types: Procedure, Procedure
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 1 year
Closest Location: Stanford University School of Medicine · Palo Alto, CA
2010First Recorded Clinical Trial
1 TrialsResearching Pilonidal Disease
673 CompletedClinical Trials
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,130 Previous Clinical Trials
35,668,510 Total Patients Enrolled
Bill Chiu, MDPrincipal InvestigatorStanford University
Eligibility Criteria
Age Any Age · All Participants · 2 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You are over the age of 8 years.\n
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments